Skip to main content
. Author manuscript; available in PMC: 2018 Oct 18.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2017 Jan 7;98(1):177–185. doi: 10.1016/j.ijrobp.2017.01.006

Table 1.

Baseline characteristics associated with receipt of IMRT among patients with anal squamous cell cancer treated with chemoradiation therapy in SEER-Medicare database

Characteristic n % treated with IMRT P value*
Entire cohort 1165 39.3
Age at diagnosis .32
    ≤65 y 318 43.1
    66–70 y 292 39.4
    71–75 y 229 35.4
    >75 y 326 38.3
Sex .005
    Male 414 44.7
    Female 751 36.4
Race .0005
    White 1037 38.0
    Nonwhite 128 50.0
Marital status .05
    Married 401 35.9
    Single 713 40.3
    Unknown 51 52.9
Comorbidity index .03
    0 643 37.2
    1 213 36.6
    ≥2 309 45.6
Disability status .78
    Good 1078 39.4
    Poor 87 37.9
HIV .06
    Yes 95 48.4
    No 1070 38.5
SEER historic stage .50
    Local 650 38.2
    Regional 424 41.5
    Unknown 91 37.4
AJCC T category .52
    T1 192 41.7
    T2 401 39.9
    T3 165 42.4
    T4 71 32.4
    Unknown or no primary identified 336 37.2
AJCC N category .06
    N0 826 39.0
    N1 64 50.0
    N2 107 43.0
    N3 53 45.3
    Unknown 115 29.6
AJCC composite stage .41
    I 156 41.0
    II 409 38.6
    III 273 42.9
    Unknown 327 36.4
Year of diagnosis <.0001
    2001–2003§ 208 5.3
    2004 or 2005 214 12.1
    2006 or 2007 213 32.4
    2008 or 2009 256 54.7
    2010 or 2011 274 77.4
SEER registry <.0001
    Northeast 149 22.1
    Midwest 102 32.4
    South 343 34.1
    West 571 48.2
Chemotherapy .05
    Mitomycin based 878 41.0
    Cisplatin based 128 29.7
    Neither mitomycin nor cisplatin based 159 37.7
PET scan at diagnosis <.0001
    Yes 483 62.5
    No 682 22.9
Dual eligible .69
    Yes 318 40.3
    No 847 39.0
SES composite .12
    First quartile (lowest) 354 37.0
    Second quartile 282 44.3
    Third quartile 273 35.5
    Fourth quartile (highest) 256 41.0
Rural-urban classification .1
    Metropolitan 984 40.3
    Urban or rural 181 33.7
HSA radiation oncologist density .0009
    First quartile (lowest) 365 31.5
    Second quartile 283 45.6
    Third quartile 271 42.8
    Fourth quartile (highest) 246 39.8
Radiation treatment center .0004
    Freestanding center 392 46.4
    Hospital-based outpatient center 773 35.7
NCI-Designated Cancer Center .0003
    Yes 58 62.1
    No 1107 38.1
Residency program .5
    Yes 482 38.2
    No 683 40.1
Provider experience with IMRT <.0001
    Upper half (>3.4 patients/y) 601 50.4
    Lower half 564 27.5

Abbreviations: AJCC = American Joint Committee on Cancer; HIV = human immunodeficiency virus; HSA = Health Service Area; IMRT = intensitymodulatedradiationtherapy;NCI = NationalCancer Institute; PET = positron emission tomography; SEER = Surveillance, Epidemiology, and End Results; SES = socioeconomic status.

*

P values are based on the Pearson χ2 test.

Patients in whom this characteristic was deemed unknown are included in this category for privacy purposes because of the low number of patients.

Single includes unmarried, divorced, separated, and widowed.

§

The 2001–2003 categories are combined in this table for privacy purposes because of the low number of IMRT patients.

West comprises the San Francisco, Hawaii, New Mexico, Seattle, Utah, San Jose, Los Angeles, and Greater California Registries; Midwest comprises the Detroit and Iowa Registries; Northeast comprises the Connecticut and New Jersey Registries; and South comprises the Atlantic, Rural Georgia, Kentucky, Louisiana, and Greater Georgia Registries.

A composite measure for area SES is presented based on the following variables from the 2000 US Census data: median household income, percentage of persons aged ≥25 years with at least a high school education, and percentage of persons living below the poverty level.